Shoring up the pharma supply chain in 2021 and beyond

The pharmaceutical supply chain has faced undeniable pressure as a result of the ongoing pandemic – which has, in turn, exposed a number of weak links.

Melaye Ras-Work, Co-founder and Vice President at Efficio, reveals the weak links, as well as four key steps pharma companies should take now to build a more robust procurement function that tackles these challenges, in a new article for Manufacturing Chemist.